CSIMarket
 


Glaukos Corp  (GKOS)
Other Ticker:  
 
 

GKOS's Free Cash Flow Growth by Quarter and Year

Glaukos's Free Cash Flow results by quarter and year




GKOS Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -10.67 -4.14 -4.65 -9.57
III Quarter September -8.17 -26.52 17.79 -10.92
II Quarter June -8.16 -12.21 7.39 -13.10
I Quarter March -30.76 9.77 4.18 -4.19
FY   -57.76 -33.10 24.71 -37.78



GKOS Free Cash Flow fourth quarter 2023 Y/Y Growth Comment
Glaukos Corp in the fourth quarter 2023 recorded free cash outflow of $ -10.67 millions.

According to the results reported in the fourth quarter 2023, Glaukos Corp achieved the best Free Cash Flow growth in Medical Equipment & Supplies industry. While Glaukos Corp' s Free Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2023.




GKOS Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - 133.73 % - -
FY   - - - -

Financial Statements
Glaukos's fourth quarter 2023 Free Cash Flow $ -10.67 millions GKOS's Income Statement
Glaukos's fourth quarter 2022 Free Cash Flow $ -4.14 millions Quarterly GKOS's Income Statement
New: More GKOS's historic Free Cash Flow Growth >>


GKOS Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - 140.73 % -
II Quarter June - - 76.79 % -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Glaukos's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GKOS's IV. Quarter Q/Q Free Cash Flow Comment
IV. Quarter 2023 accomplishment of -10.67 millions by Glaukos Corp come out even worse compare to the free cash outflow -8.17 millions a quarter before.

Within Medical Equipment & Supplies industry Glaukos Corp achieved highest sequential Free Cash Flow growth. While Glaukos's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GKOS's IV. Quarter Q/Q Free Cash Flow Comment
Current accomplishment of -10.67 millions by Glaukos Corp appear even worse considering the -8.17 millions free cash outflow in the third quarter.

Within Medical Equipment & Supplies industry Glaukos Corp achieved highest sequential Free Cash Flow growth. While Glaukos's Free Cash Flow growth quarter on quarter, overall rank is .


Glaukos's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Free Cash Flow 12 Months Ending $ -37.51 $ -26.97 $ -42.64 $ -43.05 $ -2.82
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Glaukos Corp' has realized cumulative trailing twelve months free cash outflow of $ -38 millions in the Dec 31 2023 period.
The business is getting worse as the cumulative free cash outflow is inflating from $ -26.97 millions in TTM ending quarter Sep 30 2023 and $ -2.227 millions for the twelve months ending in the quarter Dec 31 2022 Brayden Hill told.

Glaukos Corp achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Glaukos Corp' has realized cumulative trailing twelve months free cash outflow of $ -38 millions in the Dec 31 2023 period.
The business is getting worse as the cumulative free cash outflow is inflating from $ -26.97 millions for the period from Sep 30 2023 to Dec 31 2022 and $ -2.227 millions for the twelve months ending in the quarter Dec 31 2022.

Glaukos Corp achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Medical Equipment & Supplies Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
GKOS's Free Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for GKOS's Competitors
Free Cash Flow Growth for Glaukos's Suppliers
Free Cash Flow Growth for GKOS's Customers

You may also want to know
GKOS's Annual Growth Rates GKOS's Profitability Ratios GKOS's Asset Turnover Ratio GKOS's Dividend Growth
GKOS's Roe GKOS's Valuation Ratios GKOS's Financial Strength Ratios GKOS's Dividend Payout Ratio
GKOS's Roa GKOS's Inventory Turnover Ratio GKOS's Growth Rates GKOS's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2023
Enzon Pharmaceuticals inc 250.00%$ 250.000 millions
Viatris Inc 236.19%$ 236.185 millions
Msa Safety Incorporated196.75%$ 196.747 millions
Livanova Plc188.50%$ 188.499 millions
Harmony Biosciences Holdings inc 187.37%$ 187.372 millions
Nature s Sunshine Products inc 168.40%$ 168.400 millions
Lemaitre Vascular Inc 163.58%$ 163.576 millions
Semler Scientific Inc 159.77%$ 159.766 millions
Electromed Inc 154.47%$ 154.472 millions
Merit Medical Systems Inc122.26%$ 122.261 millions
Privia Health Group Inc 119.87%$ 119.870 millions
Healthcare Services Group Inc 115.98%$ 115.983 millions
National Healthcare Corp115.63%$ 115.628 millions
Becton Dickinson And Company114.29%$ 114.286 millions
Resmed Inc 112.10%$ 112.096 millions
Icon Plc106.11%$ 106.106 millions
Teladoc Health Inc 98.45%$ 98.450 millions
Bioventus Inc 97.83%$ 97.826 millions
Tenet Healthcare Corp95.72%$ 95.724 millions
Utah Medical Products Inc84.03%$ 84.032 millions
Lifevantage Corp81.70%$ 81.696 millions
Alpha Pro Tech Ltd 81.35%$ 81.346 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com